117 related articles for article (PubMed ID: 38288749)
1. Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study.
Wambach M; Montani M; Runz J; Stephan C; Jung K; Moch H; Eberli D; Bernhardt M; Hommerding O; Kreft T; Cronauer MV; Kremer A; Mayr T; Hauser S; Kristiansen G
APMIS; 2024 Apr; 132(4):256-266. PubMed ID: 38288749
[TBL] [Abstract][Full Text] [Related]
2. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
Bu H; Bormann S; Schäfer G; Horninger W; Massoner P; Neeb A; Lakshmanan VK; Maddalo D; Nestl A; Sültmann H; Cato AC; Klocker H
Prostate; 2011 May; 71(6):575-87. PubMed ID: 20945500
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of anterior gradient gene AGR2 in prostate cancer.
Maresh EL; Mah V; Alavi M; Horvath S; Bagryanova L; Liebeskind ES; Knutzen LA; Zhou Y; Chia D; Liu AY; Goodglick L
BMC Cancer; 2010 Dec; 10():680. PubMed ID: 21144054
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients.
Zhang Y; Forootan SS; Liu D; Barraclough R; Foster CS; Rudland PS; Ke Y
Prostate Cancer Prostatic Dis; 2007; 10(3):293-300. PubMed ID: 17457305
[TBL] [Abstract][Full Text] [Related]
5. Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas.
Riener MO; Thiesler T; Hellerbrand C; Amann T; Cathomas G; Fritzsche FR; Dahl E; Bahra M; Weichert W; Terracciano L; Kristiansen G
Eur J Cancer; 2014 Jul; 50(10):1722-1730. PubMed ID: 24794000
[TBL] [Abstract][Full Text] [Related]
6. Cancer-secreted AGR2 induces programmed cell death in normal cells.
Vitello EA; Quek SI; Kincaid H; Fuchs T; Crichton DJ; Troisch P; Liu AY
Oncotarget; 2016 Aug; 7(31):49425-49434. PubMed ID: 27283903
[TBL] [Abstract][Full Text] [Related]
7. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.
Darb-Esfahani S; Fritzsche F; Kristiansen G; Weichert W; Sehouli J; Braicu I; Dietel M; Denkert C
Virchows Arch; 2012 Aug; 461(2):109-16. PubMed ID: 22752467
[TBL] [Abstract][Full Text] [Related]
8. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.
Zhang Y; Ali TZ; Zhou H; D'Souza DR; Lu Y; Jaffe J; Liu Z; Passaniti A; Hamburger AW
Cancer Res; 2010 Jan; 70(1):240-8. PubMed ID: 20048076
[TBL] [Abstract][Full Text] [Related]
9. Anterior gradient 2 and 3--two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells.
Bu H; Schweiger MR; Manke T; Wunderlich A; Timmermann B; Kerick M; Pasqualini L; Shehu E; Fuchsberger C; Cato AC; Klocker H
FEBS J; 2013 Mar; 280(5):1249-66. PubMed ID: 23294566
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cell phenotypes based on AGR2 and CD10 expression.
Ho ME; Quek SI; True LD; Morrissey C; Corey E; Vessella RL; Dumpit R; Nelson PS; Maresh EL; Mah V; Alavi M; Kim SR; Bagryanova L; Horvath S; Chia D; Goodglick L; Liu AY
Mod Pathol; 2013 Jun; 26(6):849-59. PubMed ID: 23348903
[TBL] [Abstract][Full Text] [Related]
11. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ
Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243
[TBL] [Abstract][Full Text] [Related]
12. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer.
Zhang JS; Gong A; Cheville JC; Smith DI; Young CY
Genes Chromosomes Cancer; 2005 Jul; 43(3):249-59. PubMed ID: 15834940
[TBL] [Abstract][Full Text] [Related]
13. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.
Mizuuchi Y; Aishima S; Ohuchida K; Shindo K; Fujino M; Hattori M; Miyazaki T; Mizumoto K; Tanaka M; Oda Y
Lab Invest; 2015 Feb; 95(2):193-206. PubMed ID: 25418581
[TBL] [Abstract][Full Text] [Related]
14. Expression of KAI1 and AGR2 in lung adenocarcinoma and their clinicopathological significance.
Ci H; Wu L
Medicine (Baltimore); 2022 Dec; 101(51):e32498. PubMed ID: 36595821
[TBL] [Abstract][Full Text] [Related]
15. AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer.
Zhou M; Gan XL; Ren YX; Chen QX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
BMC Cancer; 2023 Aug; 23(1):743. PubMed ID: 37568077
[TBL] [Abstract][Full Text] [Related]
16. Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.
Kani K; Malihi PD; Jiang Y; Wang H; Wang Y; Ruderman DL; Agus DB; Mallick P; Gross ME
Prostate; 2013 Feb; 73(3):306-15. PubMed ID: 22911164
[TBL] [Abstract][Full Text] [Related]
17. Anterior gradient 2 regulates cancer progression in
Takabatake K; Konishi H; Arita T; Kataoka S; Shibamoto J; Furuke H; Takaki W; Shoda K; Shimizu H; Yamamoto Y; Komatsu S; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34713298
[TBL] [Abstract][Full Text] [Related]
18. Expression of AGR2 in non small cell lung cancer.
Fritzsche FR; Dahl E; Dankof A; Burkhardt M; Pahl S; Petersen I; Dietel M; Kristiansen G
Histol Histopathol; 2007 Jul; 22(7):703-8. PubMed ID: 17455144
[TBL] [Abstract][Full Text] [Related]
19. Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2.
Wu J; Wang C; Li X; Song Y; Wang W; Li C; Hu J; Zhu Z; Li J; Zhang W; Lu Z; Yang CJ
PLoS One; 2012; 7(9):e46393. PubMed ID: 23029506
[TBL] [Abstract][Full Text] [Related]
20. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.
Barraclough DL; Platt-Higgins A; de Silva Rudland S; Barraclough R; Winstanley J; West CR; Rudland PS
Am J Pathol; 2009 Nov; 175(5):1848-57. PubMed ID: 19834055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
